Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Disease|May 22, 2025
Efficacy of Amplatzer device for endobronchial treatment of hemoptysis: case seriesLev Freidkin, Ramzi Zamaereh, Shimon Izhakian, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 13, 2021
Nontuberculous Mycobacterial Pulmonary Infection Among Lung Transplant RecipientsShimon Izhakian, Assaf Frajman, Ori Mekiten, et al.
Respiratory Research|July 15, 2024
Phenotypical characteristics of nontuberculous mycobacterial infection in patients with bronchiectasisAssaf Frajman, Shimon Izhakian, Ori Mekiten, et al.
The Israel Medical Association Journal : IMAJ|March 22, 2023
Lung Transplantation for Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-center ExperienceDorit Shitenberg, Barak Pertzov, Moshe Heching, et al.
Journal of Thoracic Disease|September 15, 2025
Native lung aspergilloma after single lung transplantation-a case seriesLior Tsviban, Mordechai R Kramer, Ludmila Fridel, et al.
ERJ Open Research|January 28, 2025
Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variantKarin Yaacoby-Bianu, Moshe Heching, Mordechai R Kramer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 13, 2022
Treatment effects of Elexacaftor/Tezacaftor/Ivacaftor in people with CF carrying non-F508del mutationsGalit Livnat, Adi Dagan, Moshe Heching, et al.
Diagnostics (Basel, Switzerland)|June 12, 2026
Large Language Models Utility for Rapid On-Site Evaluation in Interventional PulmonologyMaayan Flaschner, Mordechai Reuven Kramer, Alex Krolik, et al.
The Israel Medical Association Journal : IMAJ|December 29, 2025
Pediatric Lung Transplantation in Israel: 29 Cases from a Single Center's ExperienceEyal Jacobi, Moshe Heching, Osnat Shtraichman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2024
Treatment effects of elexacaftor/tezacaftor/ivacaftor on people with cystic fibrosis heterozygous for 3849+10kbC->T and a class I variantMoshe Heching, Michal Shteinberg, Inbal Golan-Tripto, et al.
Pageof 4